Potential urinary miRNA-141 as a biomarker for detection of prostate cancer by using screen printed carbon electrode based electrochemical microRNA sensor

Weng, Wenjuan; Pang, C.C.; Pang, Shuhua; Lin, Yanyan; Yu, Kakimoto

doi:10.1016/s1569-9056(19)33366-4

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[224][225][226][227] The miRNA-145-5p was identified as an oncogene in PCa. [228] In 2019, miRNA-141 was reported as a diagnostic marker for PCa. [229] Subsequently, Wang et al [230] designed and analyzed a novel fluorescent biosensor that promoted the clinical diagnosis of PCa.…”

Section: Prostate Cancer (Pca)mentioning

confidence: 99%

Current Trends of Raman Spectroscopy in Clinic Settings: Opportunities and Challenges

Wang,

Fang,

Wang

et al. 2023

Advanced Science

View full text Add to dashboard Cite

Early clinical diagnosis, effective intraoperative guidance, and an accurate prognosis can lead to timely and effective medical treatment. The current conventional clinical methods have several limitations. Therefore, there is a need to develop faster and more reliable clinical detection, treatment, and monitoring methods to enhance their clinical applications. Raman spectroscopy is noninvasive and provides highly specific information about the molecular structure and biochemical composition of analytes in a rapid and accurate manner. It has a wide range of applications in biomedicine, materials, and clinical settings. This review primarily focuses on the application of Raman spectroscopy in clinical medicine. The advantages and limitations of Raman spectroscopy over traditional clinical methods are discussed. In addition, the advantages of combining Raman spectroscopy with machine learning, nanoparticles, and probes are demonstrated, thereby extending its applicability to different clinical phases. Examples of the clinical applications of Raman spectroscopy over the last 3 years are also integrated. Finally, various prospective approaches based on Raman spectroscopy in clinical studies are surveyed, and current challenges are discussed.

show abstract